跳转至内容
Merck

71230

Sigma-Aldrich

硫柳汞钠

97.0-101.0% (on dried substance, T)

别名:

Mercury-([o-carboxyphenyl]thio)ethyl 钠盐, 乙基噻吩酸 钠盐, 乙汞硫柳酸钠, 乙汞硫水杨酸 钠盐

登录查看公司和协议定价


About This Item

线性分子式:
2-(C2H5HgS)C6H4CO2Na
CAS号:
分子量:
404.81
Beilstein:
8169555
EC號碼:
MDL號碼:
分類程式碼代碼:
51473202
PubChem物質ID:
NACRES:
NA.21

品質等級

化驗

97.0-101.0% (on dried substance, T)

形狀

powder

mp

234-237 °C (dec.) (lit.)

作用方式

enzyme | inhibits

SMILES 字串

[Na+].CC[Hg]Sc1ccccc1C([O-])=O

InChI

1S/C7H6O2S.C2H5.Hg.Na/c8-7(9)5-3-1-2-4-6(5)10;1-2;;/h1-4,10H,(H,8,9);1H2,2H3;;/q;;2*+1/p-2

InChI 密鑰

RTKIYNMVFMVABJ-UHFFFAOYSA-L

正在寻找类似产品? 访问 产品对比指南

生化/生理作用

硫柳汞是一种巯基(硫醇)氧化剂,能抑制多种巯基依赖性酶和蛋白质,如PI3激酶依赖性蛋氨酸合成酶、谷氨酸转运受体和Na++K+依赖性ATP酶。

分析報告

溶解度(EP/BP)易溶于水,微溶或溶于乙醇(96%),几乎不溶于乙醚和二氯甲烷。

其他說明

作为公司支持《关于汞的水俣公约》消除含汞化合物全球计划的一部分,自2021年1月起,将要求客户提供最终用途声明。硫柳汞钠的销售仅限于批准应用。

訊號詞

Danger

危險分類

Acute Tox. 1 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - STOT RE 2 Oral

標靶器官

Kidney

儲存類別代碼

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges


Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Ildiko R Dunay et al.
Antimicrobial agents and chemotherapy, 48(12), 4848-4854 (2004-11-25)
Acute therapy with pyrimethamine plus sulfadiazine is the treatment of choice for reactivated toxoplasmic encephalitis (TE). Acute therapy is followed by lifelong maintenance therapy (secondary prophylaxis) with the same drugs at lower dosages. The use of pyrimethamine plus sulfadiazine is
John M Feller et al.
The Journal of clinical endocrinology and metabolism, 93(9), 3560-3567 (2008-06-12)
Hyperinsulinism with islet cell hyperplasia is a frequent complication, of unknown cause, in hemolytic disease of the newborn, occurring in Rh(D)-positive infants of Rh-isoimmunized Rh(D)-negative mothers, but not in infants with other hemolytic disorders. We investigated the possibility that trans-placentally
Pan-Chyr Yang et al.
Journal of the Formosan Medical Association = Taiwan yi zhi, 111(6), 333-339 (2012-07-04)
This study evaluated the immune response elicited by two formulations of an AS03(A)-adjuvanted H5N1 A/Indonesia/05/2005 prepandemic influenza vaccine, developed using manufacturing processes with or without thiomersal. In addition, it also evaluated compliance to the Centre for Biologics Evaluation and Research
José G Dórea
Clinica chimica acta; international journal of clinical chemistry, 411(21-22), 1580-1586 (2010-07-20)
To compare epidemiological studies dealing with neurological issues (compatible with Hg toxicity) linked to exposing newborns and infants to intramuscular doses of preservative-Hg resulting from vaccination with thimerosal-containing vaccines (TCV). Major databases were searched for studies that addressed neurodevelopment outcomes
L K Ball et al.
Pediatrics, 107(5), 1147-1154 (2001-05-23)
On July 7, 1999, the American Academy of Pediatrics and the US Public Health Service issued a joint statement calling for removal of thimerosal, a mercury-containing preservative, from vaccines. This action was prompted in part by a risk assessment from

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门